Singapore markets close in 3 hours 33 minutes

Ono Pharmaceutical Co., Ltd. (OPHLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.58-0.16 (-1.12%)
At close: 01:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.96B
Enterprise value 5.70B
Trailing P/E 8.51
Forward P/E 13.87
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.17
Price/book (mrq)1.34
Enterprise value/revenue 1.77
Enterprise value/EBITDA 4.87

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 3-22.20%
S&P500 52-week change 328.04%
52-week high 319.89
52-week low 314.47
50-day moving average 315.75
200-day moving average 317.47

Share statistics

Avg vol (3-month) 3688
Avg vol (10-day) 31.21k
Shares outstanding 5469.65M
Implied shares outstanding 6476.83M
Float 8453.32M
% held by insiders 115.55%
% held by institutions 146.84%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.52
Forward annual dividend yield 43.55%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 3542.56%
5-year average dividend yield 4N/A
Payout ratio 430.01%
Dividend date 325 Jun 2018
Ex-dividend date 427 Sept 2024
Last split factor 25:1
Last split date 329 Mar 2016

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024


Profit margin 25.46%
Operating margin (ttm)13.58%

Management effectiveness

Return on assets (ttm)11.13%
Return on equity (ttm)16.56%

Income statement

Revenue (ttm)502.67B
Revenue per share (ttm)1,047.21
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA 178.07B
Net income avi to common (ttm)127.98B
Diluted EPS (ttm)1.71
Quarterly earnings growth (yoy)2.10%

Balance sheet

Total cash (mrq)204.6B
Total cash per share (mrq)435.64
Total debt (mrq)8.86B
Total debt/equity (mrq)1.11%
Current ratio (mrq)3.99
Book value per share (mrq)1,688.42

Cash flow statement

Operating cash flow (ttm)110.66B
Levered free cash flow (ttm)49.81B